Hit enter to search or ESC to close
Red Light Holland
  • Home
  • Our Companies
    • Filament Health
    • FarmCare
    • SR Wholesale
    • Happy Caps
    • Red Light Farms
    • MiniChamp BV Mushroom Farm
    • Products
  • Team
    • Corporate Leadership
    • Board of Directors
    • Scientific Advisor
    • Advisory Board
    • Creative Consultants
  • Investors
    • Company News
    • Corporate Info
    • AGSM
  • About
    • Intro
    • Core Business
  • Media
  • Contact
All Posts By

redlighthollandadmin1

Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health to Supply Belgium’s First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression

redlighthollandadmin1
redlighthollandadmin1October 16, 2026
Company News

Rhelion Life Sciences Reappoints Dr. Robin Carhart-Harris as Scientific Advisor

redlighthollandadmin1
redlighthollandadmin1October 14, 2026
Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIV

redlighthollandadmin1
redlighthollandadmin1October 8, 2026
Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Calgary for Phase 2 Trial of Psilocybin-Assisted Therapy for PTSD in Survivors of Intimate Partner Violence

redlighthollandadmin1
redlighthollandadmin1September 29, 2026
Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Expands Supply Agreement with the University of Chieti-Pescara for PEX010 in the TEMPO Clinical Trial of Psilocybin for Treatment-Resistant Depression in Italy

redlighthollandadmin1
redlighthollandadmin1September 25, 2026
Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Issued New Canadian Patent, Extending the Broadest Natural Psilocybin Patent Estate

redlighthollandadmin1
redlighthollandadmin1September 22, 2026
Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute’s Phase 3 Trial of Microdose Psilocybin in Palliative Care

redlighthollandadmin1
redlighthollandadmin1September 21, 2026
Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin

redlighthollandadmin1
redlighthollandadmin1September 17, 2026
Company News

Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the University of Southern California for PEX010 in a Trial for Psilocybin-Assisted Mindfulness Therapy

redlighthollandadmin1
redlighthollandadmin1September 15, 2026
Company News

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

redlighthollandadmin1
redlighthollandadmin1September 14, 2026
1 2 3 … 28 Next

CONTACT

Red Light Holland
1 Adelaide St. E., Suite 801
Toronto, Ontario, M5C 2V9

Telephone: (647) 204-7129
Email: todd@redlight.co

NEWSLETTER

Subscribe to our newsletter to stay up to date with our latest developments.

© 2026 Red Light Holland.   Privacy Policy

  • Home
  • Our Companies
    • Filament Health
    • FarmCare
    • SR Wholesale
    • Happy Caps
    • Red Light Farms
    • MiniChamp BV Mushroom Farm
    • Products
  • Team
    • Corporate Leadership
    • Board of Directors
    • Scientific Advisor
    • Advisory Board
    • Creative Consultants
  • Investors
    • Company News
    • Corporate Info
    • AGSM
  • About
    • Intro
    • Core Business
  • Media
  • Contact
This website uses cookies to ensure you get the best experience on our website. Details can be found in our Privacy Policy
Read MoreACCEPT ALL
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Join Our Newsletter